Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis

• Main Authors: Cozen M.L., Ryan J.C., Shen H., Lerrigo R., Yee R.M., Sheen E., Wu R., Monto A.
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2019
• Subjects: alpha interferon; peginterferon alpha; ribavirin; adult; aged; article; clinical assessment; controlled study; disease association; drug treatment failure; female; follow up; hepatitis C; human; human tissue; liver biopsy; liver cirrhosis; liver fibrosis; major clinical study; male; overall survival; patient attitude; retrospective study; risk assessment; risk factor; treatment outcome; complication; disease course; Hepatitis C, Chronic; middle aged; recurrent disease; reproducibility; survival; time; treatment failure; Hepatitis C virus; Aged; Disease Progression; Female; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Recurrence; Reproducibility of Results; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Treatment Failure
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161328
• Institution: National University of Singapore

10.1371/journal.pone.0061568